# Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease

Study · id `cardio:ct-nct07843004` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07843004](<https://clinicaltrials.gov/study/NCT07843004>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07843004

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 4000 participants.

## Technical summary

Registry record NCT07843004. Randomized; no masking; primary purpose screening. Start 2026-09-16 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 4000 participants (planned count; ClinicalTrials.gov record NCT07843004, source copy `cardio:ctgov-nct07843004-2026-11-09`, retrieved 2026-11-18)
- Started: 2026-09-16 (actual) (ClinicalTrials.gov record NCT07843004, source copy `cardio:ctgov-nct07843004-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT07843004, source copy `cardio:ctgov-nct07843004-2026-11-09`, retrieved 2026-11-18)
- Completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT07843004, source copy `cardio:ctgov-nct07843004-2026-11-09`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07843004, source copy `cardio:ctgov-nct07843004-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07843004-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
- Acronym: CACTUS
- Condition: Structural Heart Abnormality
- Condition: Valve Heart Disease
- Condition: Heart Diseases
- Condition: Cardiovascular Diseases
- Intervention (Device): EHR Alert
- Lead sponsor: Pierre Elias
- Lead sponsor class: OTHER
- Collaborator: Edwards Lifesciences
- Collaborator class: INDUSTRY
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as a collaborator: Edwards Lifesciences (`cardio:edwards-lifesciences`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 431f9e455cde5288936619bbf56c136a2fa188c568942ed2e7fb1fb78c299f7b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
